GBA MDS is one of Europe’s leading providers for the qualification and assessment of medical devices. The portfolio includes laboratory analyses and other services in connection with the qualification of the biological compatibility of medical devices and their materials, the qualification of manufacturing, cleaning, packaging, sterilization processes and packaging systems as well as the validation of the reprocessability of medical devices.
Next year, GBA Medical Device Services GmbH will also expand its portfolio in response to strong customer demand and provide an even more comprehensive range of analyses for medical device customers.
"We would like to thank our employees at GBA MDS for their tireless commitment and hard work, which made this development possible in the first place. We are proud not only to create an attractive working environment with our new site, but also to set new milestones in terms of sustainability," say Felix Bunde and Dr Timo Lebold, Managing Directors of GBA MDS.
According to plans, the new location in Gilching will be ready for occupancy in summer 2024.
GBA Group is an international life science services company with over 2,000 employees in 8 countries and a wide range of analytical, logistical and specialist services in the fields of pharmaceuticals, medical devices, cosmetics, chemicals, food, drinking water and the environment. The GBA Group stands for outstanding technical expertise, efficient processes and full focus on customer benefits with regard to its activities in the fields of research, product development, market development and consumer protection. With its services, GBA Group directly and indirectly makes a sustainable contribution to health, the environment and society.
GBA GROUP
Goldtschmidtstraße 5
21073 Hamburg
Telefon: +49 (40) 797172-0
Telefax: +49 (40) 797172-27
https://www.gba-group.com
Head of Corporate Communication
E-Mail: presse@gba-group.de
